In this study, we introduce a SERS‐based approach coupled with a deep learning model to intraoperatively determine IDH1 status in glioma patients by determining GSH and H2O2 concentrations on freshly excised tumor tissue. The gene discussed is IDH1; the disease is central nervous system cancer.